---
title: "Helix Energy Solutions Group merger cleared by FTC; closing expected H2 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289598646.md"
description: "Helix Energy Solutions Group announced that the U.S. Federal Trade Commission granted early termination of the HSR waiting period for its planned merger with Hornbeck Offshore Services. The transaction, structured as a two-step merger, is expected to close in the second half of 2026, pending shareholder approval and other customary conditions."
datetime: "2026-06-12T12:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289598646.md)
  - [en](https://longbridge.com/en/news/289598646.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289598646.md)
generator: "portal-rs"
---

# Helix Energy Solutions Group merger cleared by FTC; closing expected H2 2026

**Helix Energy Solutions Group announced that the FTC granted early HSR termination for its planned merger, with close expected in the second half of 2026.**

**Key Highlights:**

-   Parent filed a merger agreement to combine Hornbeck Offshore Services into Helix’s subsidiaries via two-step mergers.
-   U.S. FTC granted early termination of the 30-day HSR waiting period on June 11, 2026, clearing an antitrust hurdle.
-   Transaction expected to close in H2 2026, subject to Parent shareholder approval, remaining regulatory approvals and customary conditions.
-   Parent has filed a Form S-4 registration statement; investors urged to read the proxy statement/prospectus for details and risks.

Original SEC Filing: HELIX ENERGY SOLUTIONS GROUP INC \[ HLX \] - 8-K - Jun. 12, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [HLX.US](https://longbridge.com/en/quote/HLX.US.md)

## Related News & Research

- [doxo settles FTC lawsuit for $2.1 million](https://longbridge.com/en/news/296424120.md)
- [FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case](https://longbridge.com/en/news/296642215.md)
- [US FTC considers requiring disclosure of personalized pricing](https://longbridge.com/en/news/296401772.md)
- [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**